Marcell A Szász

Summary

Affiliation: Semmelweis University
Country: Hungary

Publications

  1. pmc Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma
    A Marcell Szász
    2nd Department of Pathology, Semmelweis University, 93 Ulloi ut, 1091, Budapest, Hungary
    Int Urol Nephrol 45:727-33. 2013
  2. doi Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis
    A M Szasz
    2nd Department of Pathology, Semmelweis University, Ulloi ut 93, Budapest 1091, Hungary
    Clin Exp Metastasis 28:55-63. 2011
  3. doi [Claudins as prognostic factors of breast cancer]
    Marcell A Szász
    Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 56:209-12. 2012
  4. pmc Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Breast Cancer Res 12:R95. 2010
  5. pmc The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
    Ivett Teleki
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    BMC Cancer 13:50. 2013
  6. ncbi [Significance of positive surgical margin in radical prostatectomy]
    Lilla Madaras
    II sz Patológiai Intézet, Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 58:204-10. 2014
  7. doi A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
    Zsuzsanna Mihály
    1st Department of Pediatrics, Semmelweis University, Budapest, Hungary
    Breast Cancer Res Treat 140:219-32. 2013

Collaborators

  • Peter Nyirady
  • Attila Majoros
  • Janina Kulka
  • Eszter Szekely
  • Peter Riesz
  • Jan Budczies
  • Barna Wichmann
  • Balazs Gyorffy
  • Zsuzsanna Varga
  • T Krenacs
  • Magdolna Dank
  • Zs Nemeth
  • Lilla Madaras
  • A Marcell Szász
  • Zsuzsanna Mihály
  • Ivett Teleki
  • A M Szasz
  • Nadine Tung
  • Miklós Romics
  • Katalin Borka
  • Pál Bata
  • Aron Somorácz
  • Ildikó Szirtes
  • Attila Szendroi
  • Máté Kormos
  • Holger Moch
  • Albert Dobi
  • Shiv Srivastava
  • Cosima Riemenschnitter
  • Philip Rosen
  • Barbel Papassotiropoulos
  • Cornelia Leo
  • Andras Lanczky
  • Cs Jakab
  • L Madaras
  • K Dede
  • M Micsinai
  • L Lukacs
  • Zs Baranyai
  • A M Tokes
  • Jane Brock
  • Judy E Garber
  • Karen Krag
  • Attila M Szász
  • Alexander Miron
  • Andrea L Richardson
  • Ji Young Kim
  • Robert D Legare
  • Ruiyang Tian
  • Jennifer Kaplan
  • Ayodele Buraimoh
  • Stuart J Schnitt
  • Katharina Fetten
  • Daniel P Silver
  • Zhigang C Wang
  • Yosuf Yassin
  • Shiva Gautam
  • Paula D Ryan
  • Dennis Sgroi
  • Laura C Collins

Detail Information

Publications7

  1. pmc Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma
    A Marcell Szász
    2nd Department of Pathology, Semmelweis University, 93 Ulloi ut, 1091, Budapest, Hungary
    Int Urol Nephrol 45:727-33. 2013
    ..We evaluate the association of both ERG and claudin-4, claudin-5, and beta-catenin expression in tumor tissues of patients with organ-confined and advanced prostatic adenocarcinomas...
  2. doi Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis
    A M Szasz
    2nd Department of Pathology, Semmelweis University, Ulloi ut 93, Budapest 1091, Hungary
    Clin Exp Metastasis 28:55-63. 2011
    ..Loss of claudin junctional molecules might contribute to tumor progression, and certain claudin expression pattern might be of prognostic relevance...
  3. doi [Claudins as prognostic factors of breast cancer]
    Marcell A Szász
    Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 56:209-12. 2012
    ..The level of expression of certain claudins can be of prognostic significance in regional lymph node metastases...
  4. pmc Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Breast Cancer Res 12:R95. 2010
    ....
  5. pmc The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
    Ivett Teleki
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    BMC Cancer 13:50. 2013
    ..In this study we correlated Cx expression and cell proliferation with disease survival and pathological response to neoadjuvant chemotherapy in breast cancers using existing classification systems...
  6. ncbi [Significance of positive surgical margin in radical prostatectomy]
    Lilla Madaras
    II sz Patológiai Intézet, Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 58:204-10. 2014
    ..Pseudo-whole mount assessment of these specimens is the basis for radio-pathological correlation, thus providing quality control for preoperative MRI as well as assisting preoperative image analysis, sampling and diagnostic workup. ..
  7. doi A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
    Zsuzsanna Mihály
    1st Department of Pediatrics, Semmelweis University, Budapest, Hungary
    Breast Cancer Res Treat 140:219-32. 2013
    ..We evaluated tamoxifen-resistance genes in three independent platforms and identified PGR, MAPT, and SLC7A5 as the most promising prognostic biomarkers in tamoxifen treated patients. ..